Pancreatic Cancer UK funds world-leading research at the cutting-edge of science. We fund research through a number of approaches. Only 2.1% of UK cancer research spend is directed towards pancreatic cancer annually. Pancreatic cancer needs bold investment to transform the future and to deliver the step change that can alter the outcome for those diagnosed with this devastating disease.
We are taking this challenge on. We are targeting this underfunding through funding schemes that support pioneering and innovative research. We are incredibly excited about the potential of our research programme now and in the future.
Coronavirus - COVID-19
We are closely monitoring developments related to the coronavirus COVID-19 pandemic and guidance from government bodies.
Due to social isolation measures and the reprioritisation of clinical professionals to frontline care, we have had to adopt new approaches and make appropriate changes to the funding schemes we deliver and research community we support.
Applying to PCUK funding
All currently open funding schemes will remain open past the previously stated deadlines and all review processes will be delayed until later in the year. For information on specific awards, please consult their dedicated webpage which will be updated as soon as we are able to confirm new timelines with funding partners.
Researchers currently funded by PCUK
If you’re a researcher or student funded by us, you or your supervisor should have already received correspondence from our research team to help you to minimise the impact of the COVID-19 pandemic on you and your work.
We are able to make a number of changes in these unprecedented times to ensure that the researchers we fund remain safe and supported and to that no ground is lost in our collective effort to tackle pancreatic cancer.
We will discuss with individual award holders the measures they require to achieve this. We’ll follow the policy of your Host Institution if any staff on a grant or students:
- are unwell
- need to self-isolate
- have caring responsibilities for someone affected.
Your Host Institution will bear the costs of your paid sick leave entitlements consistent with its own employment policies.
As the situation progresses, we are aware that clinical academics and research nurses may be seconded back to the NHS to support front line service delivery. PCUK will fully support this request; the urgent patient care comes first and you can return to clinical practice if required. For clinical academics seconded back to the NHS, our expectation is that the NHS will cover your salary whilst working on the COVID-19 response. We’re continuing these discussions across the sector.
We will update this page as required.